LEADER 03988nam 2200649Ia 450 001 9910455752303321 005 20200520144314.0 010 $a0-306-48382-3 024 7 $a10.1007/b100540 035 $a(CKB)111087026983456 035 $a(EBL)3035979 035 $a(SSID)ssj0000097085 035 $a(PQKBManifestationID)11114157 035 $a(PQKBTitleCode)TC0000097085 035 $a(PQKBWorkID)10103934 035 $a(PQKB)11609456 035 $a(DE-He213)978-0-306-48382-0 035 $a(MiAaPQ)EBC3035979 035 $a(MiAaPQ)EBC234381 035 $a(Au-PeEL)EBL3035979 035 $a(CaPaEBR)ebr10067393 035 $a(OCoLC)517835813 035 $a(Au-PeEL)EBL234381 035 $a(OCoLC)936902720 035 $a(EXLCZ)99111087026983456 100 $a20030318d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAdamantiades-Behc?et's disease$b[electronic resource] /$fedited by Christos C. Zouboulis 205 $a1st ed. 2003. 210 $aNew York $cKluwer Academic/Plenum Publishers$dc2003 215 $a1 online resource (684 p.) 225 1 $aAdvances in experimental medicine and biology ;$vv. 528 300 $aDescription based upon print version of record. 311 $a0-306-47757-2 320 $aIncludes bibliographical references and index. 327 $aHistory -- Epidemiology -- Diagnostic criteria, prognostic parameters, assessment of disease activity, and quality of life -- Pathogenesis -- Genetics -- Immunology -- Concepts for research -- Mucocutaneous manifestations -- ocular manifestations -- Neurological manifestations -- Cardiovascular involvement -- Various clinical manifestations -- Treatment -- Patient-physician relationship -- Index. 330 $aIt is with great pleasure that I write this Foreword to the Proceedings of the International Conference on Behçet?s Disease which was held in Berlin in June 2002. This was the first International Conference held under the auspices of the International Society for Behçet?s Disease which was founded in 2000 in Seoul. First, I congratulate our colleagues in Berlin, led by Professor Christos Zouboulis of the Department of Dermatology at the Free University of Berlin, for having organised a most successful conference and for having compiled these proceedings so rapidly. It will be realised immediately on scanning the contents of this book that the conference was truly international with 210 participants from 26 countries, as Professor Zouboulis has noted in his preface. These included basic scientists, epidemiologists, pathologists, clinicians and, importantly, representatives from patient organisations. The latter held their own conference alongside the scientific-medical conference to mutual benefit. The combined session of patients and doctors (abstracts on pp 601 ? 626) gave the opportunity for an exchange of information and fruitful discussion. The wide ranging scope of the communications is evident from the index and it was most encouraging to see their origin ? from all parts of the world, from senior and junior colleagues and, from many different disciplines. Many communications may be regarded as preliminary reports of research in progress and we look forward to seeing the definitive publications in appropriate journals in due course. 410 0$aAdvances in experimental medicine and biology ;$vv. 528. 606 $aBehc?et's disease$vCongresses 606 $aCommunicable diseases$vCongresses 608 $aElectronic books. 615 0$aBehc?et's disease 615 0$aCommunicable diseases 676 $a616.9 701 $aZouboulis$b Christos C$0846065 712 12$aInternational Conference on Behğcet's Disease 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910455752303321 996 $aAdamantiades-Behc?et's disease$91889974 997 $aUNINA